Value Chain, Stakeholder Analysis and Trends by 2028 – Market Research Blog

Automatic blood processing equipment is used to collect blood and process whole blood sample. The primary use of whole blood is as a source for preparing blood components such as erythrocytes (red blood cells), leukocytes (white blood cells), platelets, plasma and other components. Automated blood processing equipment helps in converting whole blood into different blood components, which are mostly used for blood transfusion and for other purposes. Reducing human intervention with minimal chances of contamination and shortening blood processing time by reducing processing steps are major benefits of automated blood processing equipment. Hospitals and blood banks focus on improving productivity without increasing laboratory burden, accelerating patient care and enhancing laboratory efficiency through automated blood processing equipment. Automated blood processing equipment provides effective results, facilitating diagnosis and treatment, and reducing emergency times with faster and reliable results than traditional blood processing equipment.

To stay ahead of your competition, request a sample –

technological improvement

A blood transfusion can be useful in many life-threatening situations such as accidents or surgery, treatment of cancer and disease (leukemia, myeloma, etc.). Whole blood should be collected and processed manually with safety measures in place, but this will be time consuming and a process prone to contamination. The main advantage of automated blood processing equipment includes reducing the number of equipment involved in apheresis processing, overcoming tedious steps and standardizing the quality of blood components. Healthcare facilities are more interested in automated blood processing equipment due to the compact features that reduce workspace and increase production efficiency.

Automated Blood Processing Equipment Market Assessment by End User

Automated blood processing equipment market

Drivers of the Automated Blood Processing Equipment Market

Increased demand for safe and improved quality of blood components, increased incidence of chronic diseases, aggressive campaigns for blood donation programs, and increased healthcare spending are the main factors driving the growth of the market during the forecast period. Technological advancements and development in donation screening test kits also play a vital role in increasing the demand for automated blood processing equipment. Changes in blood collection procedures and the gradual transition of manual blood processing to automated processing machine are all set to benefit market growth. The major market manufacturers are also expanding the value chain in order to integrate the market into developing economies. In most developed countries, increased investment in terms of healthcare spending and investment in healthcare facilities by government authorities is increasing the demand for automated blood processing equipment.

Regional Market Outlook

North America leads the market for automated blood processing equipment due to the development of healthcare infrastructure, government support and the availability of advanced blood collection facilities. Western Europe is the second largest market for automated blood processing equipment due to the increase in blood donation centers and blood transfusion sites which increase the demand. The increase in chronic diseases and the volume of surgical procedures are major factors that have led to an increase in the demand for pathogen-free blood and its components, increasing the demand for automated blood processing equipment. The Asia Pacific region excluding China and Japan market is also expected to grow at a higher rate due to improved healthcare spending on capital equipment to enhance automation in facilities and a large target patient pool.

Competition prospects

Some of the players identified in the GM blood processing equipment market are Beckman Coulter, Inc, Fresenius Kabi AG, Terumo Corporation, Immucor, Macopharma. , Grifol, et al. Companies focus on innovating their automated blood processing equipment in order to reduce manufacturing costs and compete in the market at reduced prices. Companies choose mergers and acquisitions as a growth strategy to expand their geographic presence.

Small scale manufacturers/suppliers

  • Imocor
  • JMS Singapore Pte Ltd
  • mola
  • LMB Technology GmbH
  • Delcon SRL.

Medium scale manufacturers/suppliers

  • Baxter Healthcare
  • makopharma
  • Grifols

Large-scale manufacturers/suppliers

  • Beckman Coulter, Inc.
  • Fresenius Kabi AG
  • Company Terumo

Key data points covered in the report

Get A Report Tailored To Fit Your Requirements Ask A Market Research Expert –

The report covers a comprehensive analysis on:

  • Automated Blood Processing Equipment Market by Product Type, End User, and Region
  • Regional market analysis for North America, Latin America, Western Europe, and Asia Pacific excluding China, Japan, Japan, Middle East and Africa by product type, end-use segments and country
  • Blood Processing Equipment Market Mechanisms and Opportunity Assessment
  • Historical actual market volume, 2013-2017
  • Automated Blood Processing Equipment Market Size And Forecast 2018-2028
  • Automated Blood Processing Equipment Market Trends / Issues / Challenges
  • Competition and participating companies

Research Methodology

The market size of automated blood processing equipment will be determined by the triangulation-based approach. A demand side approach will be taken to assess the actual market size of automated blood processing equipment. Secondary research will be used in the initial phase to determine the feasibility of targeted services and their segments in end-use facilities and the future impact of new technologies. Each piece of information will eventually be analyzed throughout the entire research project, helping to build a strong base of primary research information.

Those involved in basic research include demand-side responders such as laboratory managers, purchasing managers, hospitals and blood bank as well as key opinion leaders as well as supply-side responders such as equipment manufacturers who provide valuable insights into trends, application of research products, technologies, purchasing patterns, services offered, and associated pricing.

Market segmentation

By product type

  • automatic blood separator
  • automatic blood handling system

by the end user

  • Hospitals
  • blood banks
  • pathology lab
  • Mobile surgery centers

by region

  • North America
  • Latin america
  • Europe
  • Asia Pacific excluding China and Japan
  • China
  • Japan
  • Middle East and Africa

For in-depth insights, download the PDF brochure –

Highlights report:

  • Changing Industry Dynamics
  • In depth market segmentation
  • Historical, current and forecast industry size, recent industry trends
  • The main competition scene, market structure, regulatory scenario
  • Epidemiological view of diseases
  • Economic Spending, Regional Healthcare Outlook, Consumer Healthcare Expenditure
  • Strategies for key players and product offerings, channel strategies, regional footprint, channel footprint
  • Potential and niche sectors/areas show promising growth
  • A neutral perspective on market performance in terms of value and volume

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market information and advisory services, serving clients in more than 150 countries. FMI is headquartered in Dubai, with delivery hubs in the UK, US and India. The latest market research and industry analysis reports from FMI help companies face challenges and make critical decisions with confidence and clarity amidst intense competition. Our customized and syndicated market research reports provide actionable insights that drive sustainable growth. FMI’s expert-led team of analysts constantly track emerging trends and events in a wide range of industries to ensure our clients are prepared for the evolving needs of their clients.

Leave a Comment